HMG - Driada Medical

Human Menopausal Gonadotropin (HMG) is a fertility treatment derived from postmenopausal women’s urine, containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This unique hormonal blend aids in ovarian stimulation, especially valuable for patients needing comprehensive hormonal support. Unlike recombinant FSH, which only offers FSH, HMG’s combined action enhances its efficacy in assisted reproductive technology (ART) for producing eggs. Studies indicate HMG’s real-world effectiveness aligns well with recombinant FSH, with some variability in patient-specific outcomes like egg retrieval numbers and birth rates. HMG’s glycosylation pattern, distinct from r-hFSH, influences its bioactivity, supporting HMG’s favorable results across ART protocols recommended by international guidelines.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about HMG by Driada Medical, consult with your doctor or healthcare professional.